New Delhi, June 24, 2022: Crysta IVF, one of India’s most trusted fertility chain has recently appointed Dr. Sweta Gupta as Medical Director.
In her new role, Dr. Sweta will be responsible for overseeing the organization’s clinical effectiveness and operational strategy in an effort to get superior treatment results. Dr. Sweta’s penchant for ethical practices, transparency, process development for quality patient care services as per current ART guidelines, will definitely take Crysta to newer heights.
A stalwart in the fertility sector both in India and overseas, Dr. Sweta’s rich experience has benefitted families at large. With over 25 years of experience, her work pedigree specifically in NHS (UK), is commendable. She has been conferred with some prestigious awards and accolades, including the Best IFS Executive 2021, ET Times Best IVF Consultant 2018, and Times Healthcare Single Specialty 2017.
She is currently an Editor of the Indian Fertility Society and is a member representative of RCOG NZ India. She is one of the few Indian medical specialists as a membership examiner of RCOG(UK) and a member of the IFS Ethical Committee. She has published many research papers in international and national journals and written chapters and edited books on ART.
In her previous professional capacity, Dr.Sweta led Medicover Fertility as Clinical Director. She was Ex Medical Director of Bournhall, Moolchand fertility and was associated with Apollo Fertility prior to joining Crysta.
Commenting on the appointment, Dheeraj Jain, Founder, Crysta IVF, said, “We are thrilled to have Dr. Sweta Gupta join our team and are certain that her experience in both the domestic and international fertility sector, will play a significant role in Crysta’s growth path. We are confident of spreading our wings under Dr. Sweta’s able guidance, patient-friendly approach, and dynamic leadership.”
Talking about her new journey, Dr. Sweta Gupta said, “Crysta IVF is the most trusted fertility chain in India, with a consistent focus on delivering superior treatment at competitive prices. I am delighted to be a part of this fast-growing organization in the field of fertility healthcare.”
Dr. Sweta’s professional qualifications include MBBS, MD(Obs&Gyne) from Lady HardingeMedical College(DU), MRCOG(UK), DFSRH(UK), FRCOG(UK), MSc (Reproduction & Development), Bristol (UK), Fellowship in Reproductive Medicine and ART(UK).
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…